ICFG France advised on building a strategic partnership in pharma logistics
Seller | Arra Group |
Target | Arra Group |
Deal Type | Mergers & Acquisitions |
Buyer | Transpharma International |
Territory | France |
Transaction Description | Under the agreement, Transpharma International acquires 40% of Arra Group’s shares. Thanks to the partnership, Arra Group will benefit from global know-how to implement its growth strategy and will provide their customers with even greater geographical and infrastructural coverage. The alliance makes the companies the leading operators in European overland distribution for the life sciences sector (FTL/LTL). Transpharma International – part of Walden and focused on delivering GDP compliant freight forwarding solutions for the healthcare and life sciences industry. Transpharma International transports healthcare products worldwide with 200 owned vehicles and a strategic network of 3000 vehicles in Europe. They offer first mile transport services covering all temperature ranges for manufacturers and distributors through its multiple locations in Europe. Walden Group – founded in 1951 in France, Walden Group is a family company driven with passion to become today’s global healthcare and supply chain solutions provider. Walden is now the European healthcare leader with a presence in 13countries, over 6,000 employees, and a turnover of €1.7 billion. |
Industry Sector | Healthcare |
ICFG Office | The Hague |
Transpharma International (part of the Walden Group) – pharmaceutical freight and logistics specialist – has entered into a strategic agreement with Arra Group, a Polish logistics company and key link in the European pharmaceutical supply chain. |